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Sarcopenia, muscle wasting, and strength decline with age, is an important cause of loss of mobility in
the elderly individuals. The underlying mechanisms are uncertain but likely to involve defects of motor
nerve, neuromuscular junction, and muscle. Loss of motor neurons with age and subsequent denervation
of skeletal muscle has been recognized as one of the contributing factors. This study investigated aspects
of mitochondrial biology in spinal motor neurons from elderly subjects. We found that protein com-
ponents of complex I of mitochondrial respiratory chain were reduced or absent in a proportion of aged
motor neuronsea phenomenon not observed in fetal tissue. Further investigation showed that complex
I-deﬁcient cells had reduced mitochondrial DNA content and smaller soma size. We propose that
mitochondrial dysfunction in these motor neurons could lead to the cell loss and ultimately denervation
of muscle ﬁbers.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
Sarcopenia is an age-related process with loss of muscle mass
and strength decline. Proposed diagnostic criteria for sarcopenia
include a gait speed of less than 1 m/s and an objectively low
muscle mass (typically 2 standard deviations below the mean
muscle mass of 35-year-old individual) (Fielding et al., 2011). Be-
tween the ages of 20 and 80 years there is approximately a 30%
reduction in muscle mass, which is reﬂected in markedly reduced
cross-sectional area of muscle (about 20%) (Frontera et al., 2000). It
has been estimated that up to 20% of people between 60 and
70 years are affected by sarcopenia, and this number increases to
50% for those aged 80 or above (von Haehling et al., 2010).
The mechanisms driving sarcopenia are uncertain but they are
likely to be multifactorial, with involvement of both muscle and the
innervating neurons (Delbono, 2003). There is good evidence of
denervation with ﬁber type grouping, accumulation of severely
atrophic angular ﬁbers, and expression of proteins associated with
denervation such as NCAM and Nav1.5 by the atrophic ﬁbers
(Andersen, 2003; Lexell and Downham, 1991; Lexell and Taylor,
1991; Urbanchek et al., 2001; Wang et al., 2005). Fibers co-e CC BY license (http://
entre for Brain Ageing and
School, Newcastle University,
8565; fax: þ44 191 2824373.
M. Turnbull).
Published by Elsevier Inc. All righexpressing myosin heavy chain slow and fast isoforms with
Nav1.5 sodium channel were detected in aged rodent gastrocne-
mius (Rowan et al., 2012), also indicating presence of denervation
as an important factor in sarcopenia across species.
Neurophysiological assessments in both animals and humans
provide further evidence of denervation of muscle with age.
Functional motor unit numbers were shown to declinewith age and
the remaining motor units became larger (Stalberg and Fawcett,
1982). In humans, a marked reduction in motor units of up to 30%
occurs between the age of 60 and 70 years (Brown et al., 1988;
Campbell et al., 1973; Doherty and Brown, 1993). Interestingly,
motor unit reduction is not immediately followed by decline in
muscle strength. It has been shown in selected muscles that a
noticeable decline in strength only occurs after a certain critical
number of motor units have been lost (McNeil et al., 2005).
Depletion of motor units is most likely caused by reduction of
the population of motor neurons residing in anterior spinal cord
and innervatingmuscle ﬁbers. Studies of lumbar spinal cord regions
from healthy human subjects ranging from 13 to 95 years have
shown a dramatic decrease in motor neuron soma counts in ventral
horns with advancing age (Lexell, 1997; Tomlinson and Irving,
1977). The mean decrease determined was around 25%, which
compares well with another study carried out on senescent rats
where a 27% reduction of motor neuron number was noted (Rowan
et al., 2012). Decrease of motor neuron soma counts is followed by
decline in axonal density in ventral lumbar spinal roots. A study by
Kawamura et al. (1977) on healthy humans (17e81 year old)ts reserved.
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between the second and 10th decade of life. Intriguingly, studies on
motor neuron loss with age from animal models provide conﬂicting
results. Some report decrease in motor unit numbers correlated
with loss of axons from innervating nerve trunks (Caccia et al.,
1979; Valdez et al., 2010), others postulate that motor neuron
pool is maintained and it is the degeneration of the neuromuscular
junction that causes denervation of muscle ﬁbers in senescent an-
imals (Chai et al., 2011; Larsson, 1995).
There is a wide range of potential contributors to motor neuronal
cell death in aging such as calcium dyshomeostasis, reduced IGF-1
signaling, proinﬂammatory cytokines, and oxidative stress (Aagaard
et al., 2010; Landﬁeld et al., 1992). However, in light of mitochon-
drial dysfunction reported in aged muscle ﬁbers (Aiken et al., 2002;
McKiernan et al., 2009) we decided to investigate mitochondrial
biology in aged motor neurons. A number of previous studies have
detected a variety of mitochondrial abnormalities in both sporadic
and familial form of motor neuron disease (MND ¼ amyotrophic
lateral sclerosis [ALS]) (Borthwick et al., 1999; Comi et al., 1998;
Wiedemann et al., 2002) but we are not aware of any systematic
exploration of mitochondrial defects in aged motor neurons, which
could relate to neurogenic changes seen in sarcopenia.
In this study we investigated mitochondrial changes in motor
neurons from a group of elderly subjects. We identiﬁed a popula-
tion of motor neurons with mitochondrial respiratory complex I
deﬁciency. We discovered that these cells had lower mitochondrial
DNA (mtDNA) copy numbers when compared with respiratory-
normal counterparts. Moreover, cell bodies of these complex I-
deﬁcient motor neurons were markedly smaller than the healthy
motor neurons.
2. Methods
2.1. Individuals studied
Lumbar region of spinal cords obtained from autopsies from 14
elderly individuals (68e99 years of age) without any diagnosed
muscle disease were used in this study. Characterization of the
individual cases is shown in Table 1. No spinal cord samples were
available from young individuals and therefore fetal spinal cords of
9e11 weeks post conception were used as a control for selected
experiments. Brain sections from a patient with a mitochondrialTable 1
Individual cases included in the study. All the cases were deprived on any muscle
conditions hence treated as healthy controls in terms of sarcopenia
Elderly individuals studied
Individual Age (y) Gender PM (h) Cause of death
Case 1 74 Male 21 MI, IHD
Case 2 87 Male 21 Heart disease
Case 3 77 Male 22 Cardio pulmonary degeneration
Case 4 68 Male 10 Colon cancer
Case 5 85 Male 23 Heart failure
Case 6 87 Female 72 Hemopericardium because of
ruptured MI
Case 7 96 Female 95 Acute subdural hematoma 1a AF
Case 8 86 Female 75 Old age
Case 9 81 Male 22 Left ventricular failure because of
MI
Case 10 74 Female 45 Pulmonary demyelinating
polyneuropathy
Case 11 73 Male 24 Left ventricular failure, coronary
artery bypass graft thrombosis
Case 12 99 Male 111 Old age
Case 13 74 Female 67 Lung cancer
Case 14 75 Female 31 Left ventricular failure because of
MI
Key: IHD, ischemic heart disease; MI, myocardial infraction; PM, post mortem delay.polymerase gmutation were also used to conﬁrm the speciﬁcity of
the methods used.
2.2. Cytochrome c oxidase and succinate dehydrogenase
histochemistry
Frozen spinal cord tissue sections, obtained from 12 elderly in-
dividuals (cut at 10 mm, obtained from Newcastle Brain Tissue
Resource and London Multiple Sclerosis Society Tissue Bank) were
mounted onto superfrost glass slides (Thermo Fisher, UK) and dried
for 1 hour at room temperature. Combined cytochrome c oxidase
(COX) and succinate dehydrogenase (SDH) enzymatic activity assay
was performed in frozen spinal cord tissue from all 12 cases as
previously described (Old and Johnson, 1989).
2.3. Immunohistochemistry to detect components of mitochondrial
respiratory chain in parafﬁn sections
Parafﬁn-embedded spinal cord sections (5 mm thick, obtained
from Newcastle Brain Tissue Resource, London Multiple Sclerosis
Society Tissue Bank and Newcastle Human Developmental Brain
Resource) were incubated at 60 C for 20 minutes, then dewaxed inFig. 1. Spinal cord tissue from 9 cases was analyzed for COX and/or SDH activity and
protein expression of mitochondrial respiratory complexes. A representative image of
respiratory-normal motor neurons in a ventral horn (brown) and a respiratory-
deﬁcient motor neuron (blue) (A). Expression of porin (mitochondrial outer mem-
brane protein), complex II subunit 70 kDa (cII-70), and complex IV subunit I (COX-I) of
mitochondrial respiratory chain were analyzed in 12 cases using IHC. Typical results are
represented by 3 cases (case 7, 8, and 13) (B). Abbreviations: COX, cytochrome c oxi-
dase; IHC, immunohistochemistry; SDH, succinate dehydrogenase. Scale bars measure
25mm (A) and 100mm (B).
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/ 100%/ 95%/ 70%) and washed in TBST. Heat-induced antigen
retrieval in 1 mM ethylenediaminetetraacetic acid pH 8.3 buffer
was carried out in a decloaker (MenaPath, A. Menarini Diagnostics,
UK) at 125 C for 1 minute. The sections were washed in TBST and
endogenous peroxidasewas quenched by incubating the sections in
3% H2O2 in TBST for 15 minutes. The sections were incubated in 5%
BSA and/or TBST solution for 30 minutes to reduce potential
nonspeciﬁc binding of primary antibodies. Primary antibodies were
applied onto the sections: subunits of complex I (cI-19, cI-20),
complex IV (COX-I), complex II (cII-70), and porin. An overnight
incubation was carried out in a humidiﬁed chamber at 4 C. The
following day, the sections were washed and the polymer detection
system was used to develop the signal (MenaPath, A. Menarini
Diagnostics, UK) as described in the following. The sections were
covered with Universal Probe and incubated for 30 minutes, then
washed in TBST and overlaid with Polymer-HRP reagent forFig. 2. Complex I protein expression detected using antibodies to 2 subunits: 19 kDa (cI-19) a
individuals. Signal was developed using DAB (brown) or Vector SG (black), nuclei were cou
shown here (cases: 1, 5, 8, and 9). Arrows indicate motor neuron cell bodies: complex I-deﬁ
reﬂects lipofuscin accumulation in motor neurons. Scale bars measure 50µm or 100mm.30minutes. Following TBSTwash, the sections were incubated with
a chromogen solution: either DAB (Sigma Fast tablets, Sigma, UK) or
Vector SG (Vector Laboratories, UK) prepared according to the
manufacturers’ instructions.
2.4. Dual immunoﬂuorescence to detect complex I and complex II in
parafﬁn spinal cord sections
Sections were deparafﬁnised, rehydrated and antigens were
retrieved as described in the previous section. Nonspeciﬁc protein
interactions were blocked by incubation with 5% normal goat
serum (5% NGS) for 30 minutes. Cocktail of primary antibodies was
prepared in the blocking solution: anti-cI-19 at 1:200 and anti-cII-
70 at 1:400 and the sections were incubated overnight at 4 C.
Following washes with TBST, the sections were incubated with
secondary antibody cocktail: anti-IgG2b-Alexa Fluor 499 (Life
Technologies, UK) at 1:200 and anti-IgG1-Alexa Fluor 546 (Lifend 20 kDa (cI-20) in parafﬁn-embedded lumbar spinal cord tissue sections from elderly
nterstained with hematoxylin (blue). Representative images obtained from 4 cases are
cient (red), complex I-reduced (yellow), and complex I-normal (blue). Uneven staining
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sections were washed and incubated with DAPI solution for 10 mi-
nutes. Autoﬂuorescence was quenched by either immersing the
slides in saturated Sudan Black in 70% ethanol for 15 minutes or
0.1% sodium borohydrite in TBS. The sections were mounted in
Vectashield permanent mounting medium (Vector Laboratories,
UK). Images were collected using Axiovision ﬂuorescent micro-
scope (Carl Zeiss, Germany).
2.5. Immunohistochemistry to detect components of complex I and
complex II in frozen spinal cord sections
Frozen blocks of lumbar spinal cords were obtained from New-
castle Brain Tissue Resource and London Multiple Sclerosis Society
Tissue Bank. Cryosections of 10 mmthicknesswere collected on glass
slides (Superfrost Plus, Thermo Fisher) and 20 mmthick cryosections
were collected on polyethylene naphthalate membrane slides (Carl
Zeiss, Germany) for subsequent laser capture procedure and mo-
lecular analysis of the dissected single cells. The sections were ﬁxed
in 4% PFA for 2minutes, washed inTBST, permeablized in gradient of
methanol (70%/ 95%þ H2O2/ 100% and 100%/ 95%þ H2O2/
70%)with 10minutes incubation in each solution. The sectionswere
washed in TBST and protein block (5% NGS for dual immunoﬂuo-
rescence or 5% BSA for immunohistochemistry (IHC) using polymer
detection system) was applied to cover each section. The sections
were incubated for 30 minutes at room temperature. Subsequent
steps were performed as described in the previous sections.
2.6. Cell counts using stereology microscope
Parafﬁn embedded lumbar spinal cord sections were stained for
cI-19 or cI-20 using Vector SG chromogen as described previously.
Twoor 3 (dependingon lumbar region) nonserial sections fromeach
casewere used for counting using a stereological workstationwith a
modiﬁed light microscope (Olympus, Japan), motorized stage, CCD
color camera and stereology software (Stereo Investigator, MBF
Bioscience, USA). On average, 150 motor neurons were counted for
each case. Entire ventral horn regionswere delineated and all motor
neuron cell bodies were included in the analysis. IHC staining was
evaluated by combined densitometry and visual inspection and theFig. 3. Complex I IHC in ventral and lateral areas of aged spinal cord obtained from case 8.
bodies in the lateral area express comparable levels of complex I proteins. Scale bars signifneurons were allocated to one of the 3 categories based on the in-
tensity of signald“þ” normal, ““ reduced, and ““ deﬁcient.
Counting and categorization of neurons was carried out by one
researcher but then veriﬁed by another person. The samples were
blinded in terms of clinical details and age of the individuals.
2.7. Preparation of the material for laser microdissection
Polyethylene naphthalate membrane slides were immuno-
ﬂuorescently dual labeled for cI-19 and cII-70 and entire ventral
horn areas were visualized using Axioimager. High-resolution
sequential images were collected at 20 magniﬁcation and sub-
sequently stitched into a map, which was used to depict complex I
deﬁcient motor neurons. The remaining slides were labeled for
complex I using Vector SG chromogen. Entire ventral horn regions
were visualized in bright ﬁeld with Axioimager and high resolution
maps were created. The same sections were subsequently stained
with Eosin to ensure that no complex I-deﬁcient motor neuron was
missed because of poor tissue morphology. Complex I-normal,
reduced, and negative motor neuron were identiﬁed and cut out of
the slides using PALM Micro Beam system (Carl Zeiss, Germany).
Individual laser microdissected neurons were captured directly into
10 mL of lysis buffer (Tris HCl,1% Tween, Proteinase K) and incubated
on ice as previously described (Murphy et al., 2008).
2.8. Analysis of mtDNA copy numbers and deletion level
Multiplex real-time PCR assay was used to detect expression
level of 2 genes: MTND1 andMTND4 simultaneously in one sample,
as described previously (Krishnan et al., 2007). Brieﬂy, lysates of
individual laser dissected motor neurons were used for real-time
PCR reaction and each cell was run in triplicate. To assess copy
number of mtDNA a standard curve was generated by creating
serially diluted template DNA of a known size and concentration.
Copy number was calculated per unit area of a dissected neuron.
Copy numbers were compared only between samples run in the
same plate on the same day to ensure reliability of data. mtDNA
deletion analysis was carried out using DDCT method where rela-
tive difference in expression of MTND1 and MTND4 gave a per-
centage value of deleted species versus wild type.cI-20 were visualized with Vector SG chromagen and cI-19 with DAB. All neuronal cell
y 100 mm. Abbreviation: IHC, immunohistochemistry. Scale bars signify 100mm.
Fig. 4. Protein expression levels of cI-19 and cI-20 (mean  SD) from 12 elderly cases.
Two to 3 sections per case were used for analysis and motor neurons were counted in
both ventral horn areas. A scale developed based on visual scoring and densitometry
allowed categorization of motor neurons into 3 groups: “þ” complex I-normal (ﬁlled
bars), ““ complex I-reduced (checked bars), ““ complex I-deﬁcient (striped bars) (A).
The proportion of motor neurons in each of the 3 groups in individual cases based on
cI-20 (B) and cI-19 immunohistochemistry (C). Abbreviation: SD, standard deviation.
K.A. Rygiel et al. / Neurobiology of Aging 35 (2014) 2230e223822342.9. Statistical analysis
For assessing statistical signiﬁcance, parametric tests were used
where the data conformed to assumptions of normality. In all other
cases nonparametric tests were used. Statistical signiﬁcance was
determined at p-value < 0.05.
3. Results
3.1. COX-deﬁcient motor neurons are uncommon in aged human
spinal cords
To investigate potential mitochondrial involvement in motor
neuron loss with age we assessed mitochondrial respiratory ca-
pacity by histochemical analysis of COX and SDH activity. We
studied a total of 342 motor neurons from 12 different cases and
only 1 COX-deﬁcient motor neuron was identiﬁed (Fig. 1A). IHC
to detect selected mitochondrial proteins showed that cII-70 and
COX-I were present in motor neurons of lumbar spinal cord from
all 12 cases (Fig. 1B). To assess mitochondrial mass we studied
the expression of porin (a mitochondrial outer membrane pro-
tein) and there was a comparable expression in all samples
(Fig. 1B).
3.2. Complex I of mitochondrial respiratory chain is impaired in
aging motor neurons
IHC for 2 components of mitochondrial respiratory chain com-
plex I: cI-19 and cI-20 highlighted a population of motor neurons
with low levels or complete lack of immunoreactivity. On the basis
of complex I expression, we categorized motor neurons into 3
groups: complex I-normal (þ), complex I-reduced (), and complex
I-deﬁcient () (Fig. 2). Complex I deﬁciency was restricted solely to
motor neurons and no other cell type within spinal cord tissue
demonstrated similar phenotype (Fig. 3).
3.3. Quantiﬁcation of complex I deﬁciency
The degree of complex I loss was quantiﬁed in 12 elderly in-
dividuals. On average 9.2  4.2% and 12.5  6.1% of motor neurons
were completely deﬁcient for cI-19 and cI-20, respectively (Fig. 4A).
Complex I-reduced cells were more abundant: 25.1  7.6% (cI-19)
and 22.7  10.5% (cI-20) (Fig. 4A). The proportion of motor neurons
in each of the 3 groups differed between individuals (Fig. 4B and C).
Although the severity of respiratory deﬁciency did not correlate
with the age in this small series, all the subjects had a degree of
complex I deﬁciency (Table 1).
3.4. Presence of complex I-deﬁcient motor neurons in elderly spinal
cords conﬁrmed by immunoﬂuorescence
To conﬁrm the complex I deﬁciency we also performed dual
immunoﬂuorescent labeling with antibodies to complex I (cI-19)
and complex II (cII-70) in the aged lumbar spinal cord tissue (Fig. 5).
A mixture of complex I-deﬁcient and/or complex I-reduced motor
neurons together with complex I-normal motor neurons were
detected in all aged ventral horns analyzed as shown in represen-
tative images obtained from case 8 (Fig. 5A and B). These results
were compared with a spinal cord section from a patient with a
known mitochondrial defect (Fig. 5C and D).
3.5. Complex I-deﬁcient motor neurons are not seen early in life
Human fetal spinal cords obtained from embryos of 9e11 weeks
post conception were subjected to IHC and immunoﬂuorescence toassess mitochondrial density as well as expression of selected
mitochondrial respiratory chain components. Motor neurons were
identiﬁed in lumbar spinal cord sections with an antibody against
ChAT and consecutive sections were labeled with cI-20, COX-I, and
cII-70 using chromogens or immunoﬂuorescence (Fig. 6A and B). No
complex I-deﬁcient cells were detected.3.6. Mitochondrial DNA copy number but not deletion
heteroplasmy level, correlates with complex I deﬁciency
Single motor neurons from 8 elderly cases were assessed using
real-time multiplex assay to measure deletion load and copy
Fig. 5. Complex I deﬁciency in aged spinal cord sections assessed with dual immunoﬂuorescence. cI-19 stained green (FITC) and subunit cII-70 stained red (TRITC), nuclei visualized
with DAPI. Parafﬁn embedded spinal cord tissue section from an elderly subject (case 8) (10magniﬁcation) (A). Single motor neurons from the same case (40magniﬁcation) (B).
Parafﬁn embedded brain section (cerebellum) from a patient with a POLG mutation, where severe complex I deﬁciency has been previously described (10magniﬁcation) (C). Single
complex I-deﬁcient motor neurons from the same brain section (40 magniﬁcation) (D). Red arrows highlight complex I-deﬁcient neurons (), blue: complex I-normal (þ) and
yellow: complex I-reduced motor neurons (). Abbreviation: POLG, polymerase g. Scale bars measure: 100 mm (A), 20 mm (B, D), and 50 µm (C).
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neurons were analyzed for each category from each case. In total
data were obtained from 119 complex I-normal motor neurons, 62
complex I-reduced motor neurons, and 101 complex I-deﬁcient
motor neurons. Although low levels (up to 50%) of mtDNA deletions
were detected in motor neurons from all 8 cases examined, there
was no statistical difference between complex I-normal (þ) com-
plex I-reduced (), and complex I-deﬁcient () subpopulations of
motor neurons (Fig. 7A).
Mitochondrial genome copy number analysis showed differ-
ences between the deﬁned motor neuron groups (Fig. 7B). All 8
cases combined showed decreased copy numbers in motor
neurons with reduced or absent complex I expression. Median
copy number normalized to a unit area (mm2) was 26.9 for
complex I-normal cells, in comparison to 17.9 and 18.6 for
complex I-reduced and complex I-deﬁcient, respectively. The
difference was statistically signiﬁcant for complex I-normal
versus complex I-reduced and complex I-normal versus com-
plex I-deﬁcient motor neurons (p-value ¼ 0.021 for þ versus 
or  using Wilcoxon rank-sum test) (Fig. 5B). This indicates that
a group of cells demonstrating reduced expression of complex I
and a group of complex I-deﬁcient cells held very similar
mtDNA density, which was lower than in cells with preserved
complex I. Copy number in individual cases are plotted in
Fig. 7C.3.7. Motor neuron size alteration
Wemeasured the area of motor neuron cell bodies belonging to
one of the 3 categories: complex I-normal, complex I-reduced, and
complex I-deﬁcient. Groups of complex I-normal and complex I-
reduced comprised motor neurons of almost identical size with
mean area values of 2289 mm2 (1110) and 2245 mm2 (1191),
respectively. Complex I-deﬁcient motor neurons, on the other hand,
were signiﬁcantly smaller than both the aforementioned groups
and measured on average 1748 mm2 (848) (p-value < 0.0001
versus complex I-normal, p-value ¼ 0.0003 versus complex I-
reduced and [Fig. 8A]). The size of motor neurons differed signiﬁ-
cantly between the individuals (Fig. 8B).
4. Discussion
Sarcopenia is an aging phenomenon with loss of both muscle
mass and strength. The etiology is likely to be multifactorial but
motor neuron loss is believed to play an important role. We report
that a signiﬁcant portion of motor neurons in elderly individuals
harbor mitochondrial complex I deﬁciency. The average level of
complex I deﬁciency was around 10% in 12 individuals aged
70e99 years. We also identiﬁed motor neurons with markedly
reduced complex I expression, which constituted about 25% of the
total spinal motor neuron pool. We detected only 1 COX-deﬁcient
Fig. 6. Expression of complex I, II, and IV in fetal spinal cords. Motor neuron population depicted in 9wpc spinal cord section by ChAT labeling using Vector SG and expression of cI-
20, COX-I, and cII-70 visualized using DAB (A). A different 9wpc fetal case dual immunolabelled for cI-20 and porin (B). In A scale bars measure 200mm (top panel) or 20 mm (bottom
panel except for the image of ChAT: 50mm). In B scale bars signify 20 mm (top panel) or 10 mm (bottom panel).
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activity and thus COX deﬁciency, unlike complex I deﬁciency, is
rare. The mitochondrial mass was preserved as both complex II and
porin remained uniformly expressed in all motor neurons. It is
important to highlight the fact that there is no evidence for
different rates of decline of mitochondrial complexes dependent on
postmortem delay (Harish et al., 2013). There was no correlation
between the length of the postmortem delay and the proportion of
complex I-deﬁcient motor neurons in our cohort (Table 1, Fig. 4).
Molecular analysis carried out on single complex I-deﬁcient and
complex I-reduced motor neurons showed that these cells con-
tained signiﬁcantly fewer mtDNA copies than healthy motor neu-
rons. Finally, we observed that the complex I-deﬁcient neurons
were signiﬁcantly smaller than both the complex I-normal and
complex I-reduced cells.
Our observation of complex I deﬁciency in aged motor neurons
is intriguing, as is its link with mtDNA depletion. There is good
evidence that in the presence of an mtDNA defect complex I is the
ﬁrst respiratory chain complex affected (Kirby et al., 1999). In
postmortem studies of patients with infantile-onset spinocerebral
ataxia, a neurodegenerative disease caused by mutations in the
mitochondrial helicase Twinkle, the cerebrum, and the cerebellum
showed severe depletion of mtDNA. As a consequence of this
mtDNA depletion, most of the neurons in the cerebellum and the
frontal cortex had reduced or completely absent immunoreactivity
against 3 complex I subunits (Hakonen et al., 2008). Interestingly,
complex II and IV immunoreactivity were unaltered in both brain
regions. These observations seem to closely resemble pattern of
mitochondrial abnormality reported inmotor neurons in this study,
although the decreasewe observed inmtDNA copy number was not
as marked. In a mouse model with tissue speciﬁc knockout ofmitochondrial transcription factor A (Ekstrand and Larsson, 2002),
mtDNA depletion in cortical neurons leads to downregulation of
mitochondrial transcripts, including complex I, and causes wide-
spread neurodegeneration (Silva and Larsson, 2002).
Other studies exploring the mitochondrial respiratory chain
protein expression in mitochondrial disease have also highlighted
that complex I deﬁciency is often the most prominent defect seen.
In a series of patients with different mitochondrial defects and
ataxia, a high proportion of cerebellar neurons had complex I
deﬁciency and only a small fraction of these neurons demonstrated
COX down-regulation. These studies also showed that there is a
progression of respiratory chain deﬁciency in the patients and COX
down-regulation appears later in the course of disease (Lax et al.,
2012). Deﬁciency of COX was strongly correlated with cell loss,
implying that COX is essential to neuronal viability. One of the
reasons we detected only very low levels of COX deﬁciency may be
that motor neurons are particularly sensitive to the defect of this
complex and thus lost before they can be detected. If this is the case
then the complex I deﬁciency we observe may be part of a pro-
gressive process which inevitably leads to the neuronal loss known
to occur with aging. Data obtained from a number of complex I
knockout animal models provide further evidence supporting that
complex I deﬁciency leads to a serious pathology. Amousemodel of
complex I deﬁciency created by knocking out NDUFS4, a nuclear
encoded complex I subunit, presented severe neurodegeneration
(Leigh syndrome-like phenotype) and death within the ﬁrst 7
weeks (Kruse et al., 2008). The same phenotype developed in mice
where NDUFS4 knockout was restricted to neurons and glia
(Quintana et al., 2010). In the wobbler mouse, which serves as a
model of amyotrophic lateral sclerosis, an isolated complex I inhi-
bition appeared in spinal motor neurons at an early stage and
Fig. 7. mtDNA deletion levels and mtDNA copy numbers in single motor neurons from
8 cases. Complex I-normal (þ), complex I-reduced (), and complex I-deﬁcient ()
cells were compared. Each dot represents percentage of deletion in mtDNA from a
single motor neuron (A). mtDNA copy numbers from complex I-normal (þ) motor
neurons were compared with complex I-reduced () and deﬁcient () motor neurons.
The difference was statistically signiﬁcant (p-value ¼ 0.021) (Wilcoxon rank-sum test).
Each dot represents copy number reading for a single neuron normalized to an area
unit (mm2) (B). Copy number of mtDNA in single motor neurons showing different
complex I status from 8 elderly cases. Copy numbers of complex I-normal were
compared with complex I-reduced and complex I-deﬁcient motor neurons (C).
Abbreviation: mtDNA, mitochondrial DNA.
Fig. 8. Size of individual motor neurons represented as area from 8 elderly cases. Each
dot shows a measurement from a single cell. Differences in area were statistically
signiﬁcant with p-value < 0.0001 (A). A comparison between complex I-normal (þ)
and complex I-reduced () versus complex I-deﬁcient () for individual cases (B).
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2002).
Aging human postmitotic tissues have been shown to accumu-
late clonally expanded mtDNA deletions causing respiratory deﬁ-
ciency (Greaves and Turnbull, 2009). In this study, however, we did
not detect signiﬁcantly increased mtDNA deletions in the complex
I-deﬁcient cells suggesting that either mtDNA deletions are not the
cause of pathology in these motor neurons or they had not accu-
mulated to high enough levels. We did observe in both the complexI-reduced and complete complex I-deﬁcient motor neurons mtDNA
depletion as compared with cells with normal complex I levels.
mtDNA depletion could result from a variety of factors including
nuclear genetic defects, limitation of nucleosides or even be sec-
ondary to relative inactivity of the neuron. Unfortunately in post-
mortem tissue it is impossible to identify the underlying
mechanism.
Another important question relates to the consequence of the
complex I defect on motor neuron function or survival. We
observed motor neuron soma size reduction in the complex I-
deﬁcient neurons. Interestingly, this was only seen in the complex I
deﬁcient neurons, suggesting that the progressive loss of complex I
level does have a direct effect on neuron function. We cannot
exclude a possibility that smaller motor neurons are more suscep-
tible to acquiring complex I damage although we believe that is less
likely scenario. We also know from patients with mitochondrial
disease that complex I deﬁciency can certainly lead to severe
neuropathological defects. The most common condition often
associated with isolated complex I deﬁciency is Leigh syndrome, a
progressive neurodegenerative condition (Fassone and Rahman,
2012; Pagliarini et al., 2008; Smeitink et al., 2004). Therefore, the
defect we have observed in motor neurons is likely to have an effect
on neuronal function and/or viability.
In conclusion, we have identiﬁed complex I deﬁciency in motor
neurons in aged human spinal cords. We believe that respiratory
chain deﬁciency in motor neurons may be an important mecha-
nism, which leads to the motor neuron dysfunction and loss in
K.A. Rygiel et al. / Neurobiology of Aging 35 (2014) 2230e22382238sarcopenia. Understanding both the causes and consequences of
this deﬁciency is important and may give new insights into future
therapeutic interventions to treat or prevent sarcopenia.
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